Literature DB >> 19847894

Modeling Parkinson's disease.

C Warren Olanow, Jeffrey H Kordower.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19847894     DOI： 10.1002/ana.21832

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  14 in total

1.  Environmental neurotoxin-induced progressive model of parkinsonism in rats.

Authors:  Wei-Bin Shen; Kimberly A McDowell; Aubrey A Siebert; Sarah M Clark; Natalie V Dugger; Kimberly M Valentino; H A Jinnah; Carole Sztalryd; Paul S Fishman; Christopher A Shaw; M Samir Jafri; Paul J Yarowsky
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

Review 2.  Therapy for Parkinson's disease: what is in the pipeline?

Authors:  Fabrizio Stocchi
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 3.  Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.

Authors:  Amaal AlDakheel; Lorraine V Kalia; Anthony E Lang
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

4.  Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.

Authors:  Yue Yong; Hanqing Ding; Zhiqin Fan; Jia Luo; Zun-Ji Ke
Journal:  Neurochem Res       Date:  2011-01-04       Impact factor: 3.996

Review 5.  Modeling Parkinson's disease in monkeys for translational studies, a critical analysis.

Authors:  Lisa F Potts; Hao Wu; Arun Singh; Irene Marcilla; Maria R Luquin; Stella M Papa
Journal:  Exp Neurol       Date:  2013-09-23       Impact factor: 5.330

Review 6.  The ongoing pursuit of neuroprotective therapies in Parkinson disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  Nat Rev Neurol       Date:  2014-12-02       Impact factor: 42.937

7.  Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism.

Authors:  Liudmila Efremova; Stefan Schildknecht; Martina Adam; Regina Pape; Simon Gutbier; Benjamin Hanf; Alexander Bürkle; Marcel Leist
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

8.  Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease.

Authors:  Chao Li; Yuan Guo; Wenjie Xie; Xingang Li; Joseph Janokovic; Weidong Le
Journal:  Neurochem Res       Date:  2010-07-16       Impact factor: 3.996

9.  Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.

Authors:  Ting Xu; Junjun Zhou; Jie Zhu; Shuai Zhang; Ning Zhang; Yan Zhao; Chunchun Ding; Xue Shi; Jihong Yao
Journal:  Metab Brain Dis       Date:  2016-12-13       Impact factor: 3.584

10.  Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells.

Authors:  K Y Chau; J M Cooper; A H V Schapira
Journal:  Neurochem Int       Date:  2010-07-17       Impact factor: 3.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.